The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin
- 1 June 1995
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Blood Coagulation & Fibrinolysis
- Vol. 6 (Sup 1), S57-S64
- https://doi.org/10.1097/00001721-199506001-00010